Search is Powered by Google
Pharma Industry / Biotech Industry News

Eli Lilly Agrees To Pay $15M To Settle Alaska Medicaid Lawsuit Filed Over Zyprexa Allegations

Main Category: Pharma Industry / Biotech Industry
Also Included In: Medical Malpractice / Litigation;  Schizophrenia
Article Date: 27 Mar 2008 - 7:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:3 and a half stars

3.5 (2 votes)

Health Professional:not yet rated

Article Opinions: 1 posts

Eli Lilly has agreed to pay $15 million to settle a lawsuit filed by the state of Alaska over allegations that the company concealed data about the side effects of Zyprexa, a schizophrenia and bipolar disorder medication, and cost the state Medicaid program millions of dollars because of an increased incidence of diabetes among beneficiaries, the Indianapolis Star reports (Spalding, Indianapolis Star, 3/26). According to the lawsuit, filed in 2006, Zyprexa led to a number of health problems -- such as weight gain, hypertension and diabetes -- in Alaska Medicaid beneficiaries (AP/Miami Herald, 3/26). The lawsuit sought $270 million in damages.

Under the settlement, which ended a trial that began on March 3, Lilly agreed to ensure that Alaska is "treated as favorably as any other state" in any future settlements of similar lawsuits (Indianapolis Star, 3/26). Lilly faces lawsuits filed by at least nine other states over allegations that the company illegally marketed Zyprexa for unapproved uses and concealed data on the side effects of the medication (Manzor, Wall Street Journal, 3/26). Lilly made no admission of wrongdoing in the settlement (AP/Miami Herald, 3/26).

Lilly general counsel Robert Armitage said that the company had a "strong defense" but decided to settle the lawsuit in the interests of all parties involved. He added, "Our decision to resolve this case does not change the fact that Zyprexa can continue to improve the lives of patients around the world who are suffering from schizophrenia and bipolar disorder" (Indianapolis Star, 3/26).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

View drug information on Zyprexa.





Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Breast Cancer Cardiovascular GI Prostate Cancer Psychiatry Respiratory Learning Resources Migraine Urology
Asthma Bipolar Blood Pressure Breast Cancer (Patient) Heartburn

Sign up to receive newsletters / news alerts
MedReader RSS Reader


Menopause - Managing the Symptoms
Menopause - Managing the Symptoms

While most women won't need to be treated for menopause, some will have symptoms severe enough to disrupt their lives. There are effective treatments to help those women cope with their symptoms.

more videos are available in our health videos section.

Add Your Advertisement Here